摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloro-4-[4-(4-fluorophenyl)-3,5-dimethyl-1H-pyrazol-1-yl]benzonitrile | 1370642-81-1

中文名称
——
中文别名
——
英文名称
2-chloro-4-[4-(4-fluorophenyl)-3,5-dimethyl-1H-pyrazol-1-yl]benzonitrile
英文别名
2-Chloro-4-[4-(4-fluorophenyl)-3,5-dimethylpyrazol-1-yl]benzonitrile
2-chloro-4-[4-(4-fluorophenyl)-3,5-dimethyl-1H-pyrazol-1-yl]benzonitrile化学式
CAS
1370642-81-1
化学式
C18H13ClFN3
mdl
——
分子量
325.773
InChiKey
PEIRPJCUYQRMEP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    41.6
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-氯-4-氟苯腈 、 sodium hydride 、 sodium carbonate溶剂黄146 作用下, 以 二甲氧基乙烷N,N-二甲基甲酰胺 、 mineral oil 为溶剂, 反应 2.18h, 生成 2-chloro-4-[4-(4-fluorophenyl)-3,5-dimethyl-1H-pyrazol-1-yl]benzonitrile
    参考文献:
    名称:
    Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists
    摘要:
    A series of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole compounds B were designed, synthesized, and evaluated for their potential as new-generation androgen receptor (AR) antagonists therapeutically effective against castration-resistant prostate cancer (CRPC). Introduction of a bulky amide substituent (R-2) to the terminal aryl ring of the 4-arylmethyl group favored the reduction of agonistic activity and improved the pharmacokinetic (PK) properties. Similarly, introduction of a bulky substituent in the 4-aryloxy derivatives also resulted in improved PK properties. Compounds 28h and 44b exhibited potent antitumor effects against a CRPC model of LNCaP-hr cell line in a mouse xenograft model. On the contrary, bicalutamide showed only partial suppression of tumor growth. These results suggest that the novel pyrazole derivatives are new-generation AR antagonists, different from the 'first-generation' antagonists such as bicalutamide in a CRPC treatment model. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.02.005
点击查看最新优质反应信息